American Journal of Epidemiology Advance Access originally published online on April 5, 2006
American Journal of Epidemiology 2006 163(11):997-1002; doi:10.1093/aje/kwj123
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Contribution |
Antibiotic Use and Risk of Multiple Sclerosis
1 Department of Epidemiology, Harvard School of Public Health, Boston, MA
2 Boston Collaborative Drug Surveillance Program, Boston University, Lexington, MA
Correspondence to Dr. Alvaro Alonso, Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115 (e-mail: aalogut{at}alumni.unav.es).
Some reports suggest that bacteria, including Chlamydophila pneumoniae, could be involved in the etiology of multiple sclerosis. If that is true, persons who used antibiotics active against these bacteria, compared with nonusers, might be at lower risk of multiple sclerosis. Using a 1993–2000 case-control study nested in the United Kingdom–based General Practice Research Database cohort, the authors identified 163 multiple sclerosis cases who were followed up for at least 3 years before their first symptoms (the index date). Up to 10 controls matched to the cases by age, sex, general practice, and time in the cohort were selected. Exposure to antibiotics was assessed through computerized medical records. Overall antibiotic use or use of antibiotics against C. pneumoniae was not associated with multiple sclerosis risk. However, use of penicillins in the 3 years before the index date decreased the risk of developing a first attack of multiple sclerosis (odds ratio = 0.5, 95% confidence interval: 0.3, 0.9 for those who used penicillins for 
15 days compared with no use). In conclusion, use of antibiotics active against C. pneumoniae was not associated with a decreased risk of short-term multiple sclerosis. The observed lower risk of multiple sclerosis for penicillin users needs to be confirmed in other populations.
anti-bacterial agents; Chlamydophila pneumoniae; multiple sclerosis; prospective studies
Abbreviations: CI, confidence interval; GPRD, General Practice Research Database; MS, multiple sclerosis; OR, odds ratio
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. L Terry, V. Chevendra, A. Thind, M. Stewart, J N. Marshall, and S. Cejic Using your electronic medical record for research: a primer for avoiding pitfalls Fam. Pract., February 1, 2010; 27(1): 121 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lindsey and S. Patel Review: PCR for bacterial 16S ribosomal DNA in multiple sclerosis cerebrospinal fluid Multiple Sclerosis, March 1, 2008; 14(2): 147 - 152. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Parratt, J. O'Riordan, R. Swingler, and D Parratt RE: "ANTIBIOTIC USE AND RISK OF MULTIPLE SCLEROSIS" Am. J. Epidemiol., December 15, 2006; 164(12): 1253 - 1253. [Full Text] [PDF]
|
|
|
|
|
|
A. Alonso, S. S. Jick, and M. A. Hernan THREE AUTHORS REPLY Am. J. Epidemiol., December 15, 2006; 164(12): 1253 - 1254. [Full Text] [PDF]
|
|